Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure

3 April 2022 (00:00 - 00:00)

Organised by:

About the speaker

Doctor Andrea Mazza

Hospital Santa Maria della Stella, Orvieto (Italy)

6 More presentations in this session

Presentation thumbnail

Prevention of early sudden cardiac death after myocardial infarction using the wearable cardioverter defibrillator - results from a real-life cohort

Doctor U. Rohrer (Graz, AT)

Abstract Slides

Presentation thumbnail

Implantable cardioverter-defibrillator therapy in the very young - Patient characteristics procedural outcome and one-year follow-up - A subgroup analysis of the german DEVICE registry

Doctor D. Chung (Hamburg, DE)

Abstract Slides

Presentation thumbnail

Age-related differences and associated outcomes of S-ICD: insights from a large, european, multicenter, real-world registry

Doctor M. Schiavone (Milan, IT)

Abstract Slides

Presentation thumbnail

Real-world survival of model-3501 subcutaneous implantable defibrillator lead

Doctor F. Migliore (Padova, IT)

Presentation thumbnail

Procedure related complications following implantation of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) devices - Insights from the German DEVICE registry

Doctor L. Kaiser (Hamburg, DE)

Abstract Slides

Access the full session

Session thumbnail

Moderated ePosters - Variety of news on device therapy

The Event

Event poster

EHRA 2022

3 April - 5 April 2022

You may be interested in

Congress Session

Debate on primary prevention in ICD therapy

Congress Session

Implantable cardioverter defibrillator therapy

Congress Session

Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources